MONUDIN Trademark

Trademark Overview


On Wednesday, August 1, 2012, a trademark application was filed for MONUDIN with the United States Patent and Trademark Office. The USPTO has given the MONUDIN trademark a serial number of 85693119. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 2, 2021. This trademark is owned by Oxford BioMedica plc. The MONUDIN trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Chemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology

Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders

Instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, empty vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization

Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy
monudin

General Information


Serial Number85693119
Word MarkMONUDIN
Filing DateWednesday, August 1, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 2, 2021
Registration Number4591003
Registration DateTuesday, August 26, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2013

Trademark Statements


Goods and ServicesChemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology
Goods and ServicesGene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders
Goods and ServicesInstruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, empty vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization
Goods and ServicesScientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 2, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 2, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxford BioMedica plc
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressOxford OX4 6LT
GB

Party NameOxford BioMedica plc
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressOxford OX44GA
GB

Party NameOxford BioMedica plc
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressOxford OX44GA
GB

Trademark Events


Event DateEvent Description
Friday, April 2, 2021CANCELLED SEC. 8 (6-YR)
Monday, August 26, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 8, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 8, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 26, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, July 22, 20141(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, June 23, 2014NOTICE OF ALLOWANCE CANCELLED
Monday, July 14, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 23, 2014TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, December 24, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 9, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 25, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 24, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 24, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 24, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 17, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 5, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 5, 2013NON-FINAL ACTION E-MAILED
Monday, August 5, 2013NON-FINAL ACTION WRITTEN
Friday, August 2, 2013PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, July 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 29, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 29, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 22, 2013ASSIGNED TO LIE
Thursday, July 18, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 21, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 21, 2013NON-FINAL ACTION E-MAILED
Monday, January 21, 2013NON-FINAL ACTION WRITTEN
Wednesday, January 9, 2013PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, December 16, 2012WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, November 29, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 28, 2012ASSIGNED TO EXAMINER
Friday, August 10, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 4, 2012NEW APPLICATION ENTERED IN TRAM